China Resources Medical Holdings Company Limited

SEHK:1515 Aktierapport

Börsvärde: HK$5.5b

China Resources Medical Holdings Framtida tillväxt

Future kriterier kontrolleras 3/6

China Resources Medical Holdings förväntas öka intäkter och intäkter med 32.1% respektive 4.3% per år. EPS förväntas tillväxt med 32% per år. Avkastningen på eget kapital förväntas bli 11.9% om 3 år.

Viktig information

32.1%

Tillväxttakt i vinsten

32.0%

Tillväxttakt för EPS

Healthcare vinsttillväxt16.7%
Intäkternas tillväxttakt4.3%
Framtida avkastning på eget kapital11.9%
Bevakning av analytiker

Low

Senast uppdaterad03 Mar 2025

Senaste uppdateringarna om framtida tillväxt

Recent updates

China Resources Medical Holdings (HKG:1515) Has Some Way To Go To Become A Multi-Bagger

Feb 20
China Resources Medical Holdings (HKG:1515) Has Some Way To Go To Become A Multi-Bagger

Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Nov 14
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

Oct 02
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Apr 26
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Mar 09
Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

Nov 29
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Oct 19
China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Aug 30
Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

Aug 26
Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Jun 30
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

May 12
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Apr 03
Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Feb 21
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

Jan 10
China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Nov 30
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

Oct 18
Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Sep 21
China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Jul 13
Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Jun 24
Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

Jun 03
China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

Apr 27
China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Apr 22
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Mar 30
Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

Jan 27
Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 03
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Nov 19
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Oct 26
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Sep 20
An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

Sep 06
Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Aug 17
China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Jun 21
Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Jun 09
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

May 03
Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Apr 22
China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Prognoser för vinst- och omsättningstillväxt

SEHK:1515 - Analytikernas framtida uppskattningar och tidigare finansiella data (CNY Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
12/31/202611,073873N/AN/A3
12/31/202510,7767861,2131,5915
12/31/202410,3027119841,2975
6/30/20249,9702946211,162N/A
3/31/202410,0392766651,179N/A
12/31/202310,1082587081,195N/A
9/30/20239,9583387321,251N/A
6/30/20239,8094197561,307N/A
3/31/20238,8553425771,086N/A
12/31/20227,901266397864N/A
9/30/20226,891365422772N/A
6/30/20225,881463447680N/A
3/31/20225,164441479695N/A
12/31/20214,447418512710N/A
9/30/20214,031410392628N/A
6/30/20213,615402271546N/A
3/31/20213,183356349595N/A
12/31/20202,751310426644N/A
9/30/20202,404313483614N/A
6/30/20202,058315540584N/A
3/31/20202,087353435475N/A
12/31/20192,115391330366N/A
9/30/20192,112401263300N/A
6/30/20192,108412196234N/A
3/31/20192,084421236284N/A
12/31/20182,059431277334N/A
9/30/20181,996364317371N/A
6/30/20181,932298357407N/A
3/31/20181,905360N/A433N/A
12/31/20171,878421N/A460N/A
9/30/20171,784-446N/A377N/A
6/30/20171,690-1,312N/A294N/A
3/31/20171,611-1,410N/A259N/A
12/31/20161,533-1,507N/A224N/A
9/30/20161,504-656N/A227N/A
6/30/20161,475196N/A230N/A
3/31/20161,424181N/A231N/A
12/31/20151,372167N/A232N/A
9/30/20151,337208N/A246N/A
6/30/20151,302249N/A261N/A
3/31/20151,254240N/A268N/A
12/31/20141,206230N/A274N/A
9/30/20141,090176N/A238N/A
6/30/2014975122N/A202N/A
3/31/2014931106N/A186N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: 1515 s prognostiserade vinsttillväxt ( 32.1% per år) är över sparkvoten ( 2.4% ).

Resultat vs marknad: 1515 s intäkter ( 32.1% per år) förväntas växa snabbare än marknaden för Hong Kong ( 11.6% per år).

Höga tillväxtresultat: 1515 s intäkter förväntas växa avsevärt under de kommande 3 åren.

Intäkt vs marknad: 1515 s intäkter ( 4.3% per år) förväntas växa långsammare än marknaden för Hong Kong ( 7.7% per år).

Hög tillväxtintäkter: 1515 s intäkter ( 4.3% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: 1515 s avkastning på eget kapital förväntas bli låg om 3 år ( 11.9 %).

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2025/03/12 09:25
Aktiekurs vid dagens slut2025/03/12 00:00
Intäkter2024/06/30
Årlig intjäning2023/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

China Resources Medical Holdings Company Limited bevakas av 26 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Ling ZhangBNP Paribas Securities (Asia)
Jessica LiBofA Global Research
Yue-Kwong LuiCGS International